Boston Family Office’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.8M Sell
68,879
-4,583
-6% -$1.07M 1.12% 25
2025
Q4
$15.2M Sell
73,462
-1,469
-2% -$290K 0.96% 32
2025
Q3
$13.9M Sell
74,931
-2,566
-3% -$440K 0.88% 37
2025
Q2
$11.8M Sell
77,497
-7,722
-9% -$1.19M 0.79% 39
2025
Q1
$14.1M Sell
85,219
-1,742
-2% -$273K 1% 32
2024
Q4
$12.6M Sell
86,961
-1,446
-2% -$224K 0.86% 35
2024
Q3
$14.3M Sell
88,407
-1,439
-2% -$229K 0.97% 34
2024
Q2
$13.1M Sell
89,846
-28
-0% -$4.16K 0.95% 32
2024
Q1
$14.2M Sell
89,874
-1,067
-1% -$170K 1.02% 30
2023
Q4
$14.3M Sell
90,941
-562
-0.6% -$86.2K 1.07% 30
2023
Q3
$14.3M Buy
91,503
+1,119
+1% +$185K 1.17% 27
2023
Q2
$15M Sell
90,384
-1,917
-2% -$309K 1.15% 28
2023
Q1
$14.3M Sell
92,301
-539
-0.6% -$87K 1.15% 29
2022
Q4
$16.4M Sell
92,840
-157
-0.2% -$27.1K 1.36% 23
2022
Q3
$15.2M Sell
92,997
-3,953
-4% -$669K 1.35% 24
2022
Q2
$17.2M Sell
96,950
-2,493
-3% -$444K 1.44% 20
2022
Q1
$17.6M Buy
99,443
+704
+0.7% +$120K 1.25% 26
2021
Q4
$16.9M Sell
98,739
-524
-0.5% -$85.8K 1.1% 28
2021
Q3
$16M Sell
99,263
-1,215
-1% -$207K 1.16% 27
2021
Q2
$16.6M Buy
100,478
+654
+0.7% +$108K 1.18% 25
2021
Q1
$16.5M Sell
99,824
-3,088
-3% -$500K 1.24% 25
2020
Q4
$16.2M Sell
102,912
-7,840
-7% -$1.16M 1.25% 22
2020
Q3
$16.5M Sell
110,752
-4,408
-4% -$652K 1.5% 18
2020
Q2
$16.2M Sell
115,160
-1,805
-2% -$263K 1.57% 15
2020
Q1
$15.3M Buy
116,965
+165
+0.1% +$23.4K 1.81% 11
2019
Q4
$17M Sell
116,800
-11,005
-9% -$1.49M 1.62% 14
2019
Q3
$16.5M Sell
127,805
-8,447
-6% -$1.11M 1.72% 12
2019
Q2
$19M Sell
136,252
-312
-0.2% -$43.2K 1.97% 10
2019
Q1
$19.1M Sell
136,564
-6,390
-4% -$856K 2.06% 6
2018
Q4
$18.4M Sell
142,954
-5,070
-3% -$707K 2.29% 5
2018
Q3
$20.5M Sell
148,024
-4,770
-3% -$634K 2.16% 4
2018
Q2
$18.5M Sell
152,794
-1,990
-1% -$248K 2.1% 5
2018
Q1
$19.8M Sell
154,784
-630
-0.4% -$85.2K 2.26% 3
2017
Q4
$21.7M Sell
155,414
-2,498
-2% -$348K 2.38% 2
2017
Q3
$20.5M Sell
157,912
-3,098
-2% -$411K 2.33% 3
2017
Q2
$21.3M Sell
161,010
-2,047
-1% -$261K 2.52% 2
2017
Q1
$20.3M Sell
163,057
-4,873
-3% -$582K 2.5% 2
2016
Q4
$19.3M Sell
167,930
-1,115
-0.7% -$129K 2.51% 2
2016
Q3
$20M Sell
169,045
-5,123
-3% -$622K 2.59% 1
2016
Q2
$21.1M Sell
174,168
-1,304
-0.7% -$148K 2.74% 1
2016
Q1
$19M Buy
175,472
+5,863
+3% +$607K 2.5% 1
2015
Q4
$17.4M Sell
169,609
-368
-0.2% -$37K 2.38% 4
2015
Q3
$15.9M Sell
169,977
-1,829
-1% -$177K 2.21% 6
2015
Q2
$16.7M Sell
171,806
-11,233
-6% -$1.12M 2.1% 6
2015
Q1
$18.4M Buy
183,039
+10
+0% +$1.02K 2.29% 4
2014
Q4
$19.1M Sell
183,029
-877
-0.5% -$92.4K 2.38% 2
2014
Q3
$19.6M Sell
183,906
-391
-0.2% -$40.6K 2.52% 3
2014
Q2
$19.3M Buy
184,297
+58
+0% +$5.86K 2.45% 2
2014
Q1
$18.1M Sell
184,239
-2,820
-2% -$261K 2.4% 4
2013
Q4
$17.1M Sell
187,059
-965
-0.5% -$88.9K 2.26% 4
2013
Q3
$16.3M Sell
188,024
-6,729
-3% -$604K 2.32% 4
2013
Q2
$16.7M Buy
+194,753
New +$16.5M 2.54% 3

Other funds holding JNJ

Boston Family Office's JNJ Position: Q1 2026 in Review

Boston Family Office reduced its Johnson & Johnson (JNJ) stake by 6.2% in Q1 2026, selling an estimated $1.07M and leaving 68,879 shares worth $16.8M. The position accounts for 1.12% of the portfolio, ranked #25.

Boston Family Office first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.7M in Q4 2017. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Boston Family Office held 68,879 shares of Johnson & Johnson worth $16.8M as of Q1 2026.
  • Boston Family Office sold 4,583 Johnson & Johnson shares in Q1 2026, an estimated $1.07M.
  • Johnson & Johnson made up 1.12% of Boston Family Office's portfolio in Q1 2026, its #25 holding.
  • Boston Family Office first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Boston Family Office's Johnson & Johnson position peaked at $21.7M in Q4 2017.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Boston Family Office's 13F filing for Q1 2026, filed 13 May 2026.